3D Medicines (思路迪, 3DMed) is a commercial-stage biopharmaceutical company that develops differentiated next-generation immuno-oncology drugs. It offers COVID-19 detection, cancer NGS, pathology AI, and other solutions. The company provides diagnosis services.